• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.用于退行性、炎症性和感染性神经系统疾病的纳米神经药物。
Nanomedicine. 2015 Apr;11(3):751-67. doi: 10.1016/j.nano.2014.12.014. Epub 2015 Jan 31.
2
Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines.为纳米神经医学启用纳米材料、纳米制造和细胞技术。
Nanomedicine. 2015 Apr;11(3):715-29. doi: 10.1016/j.nano.2014.12.013. Epub 2015 Jan 31.
3
Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders.基于建模和纳米技术方法的应用:中枢神经系统疾病治疗诊断学中的突破性进展
Life Sci. 2017 Aug 1;182:93-103. doi: 10.1016/j.lfs.2017.06.001. Epub 2017 Jun 3.
4
Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting.用于中枢神经系统诊断与治疗的成像与纳米医学:第十一届血脑屏障破坏联盟年度会议报告
AJNR Am J Neuroradiol. 2006 Mar;27(3):715-21.
5
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases.用纳米药物治疗中枢神经系统疾病:实现基因治疗的承诺。
Adv Sci (Weinh). 2022 Sep;9(26):e2201740. doi: 10.1002/advs.202201740. Epub 2022 Jul 18.
6
Nanomaterial applications in multiple sclerosis inflamed brain.纳米材料在多发性硬化症炎症大脑中的应用。
J Neuroimmune Pharmacol. 2015 Mar;10(1):1-13. doi: 10.1007/s11481-015-9588-y. Epub 2015 Jan 24.
7
Novel central nervous system drug delivery systems.新型中枢神经系统药物传递系统。
Chem Biol Drug Des. 2014 May;83(5):507-20. doi: 10.1111/cbdd.12268. Epub 2014 Mar 14.
8
Multiple sclerosis: Therapeutic applications of advancing drug delivery systems.多发性硬化症:药物传递系统进展的治疗应用。
Biomed Pharmacother. 2017 Feb;86:343-353. doi: 10.1016/j.biopha.2016.12.010. Epub 2016 Dec 21.
9
The 4th Annual Meeting of the American Society for Nanomedicine.美国纳米医学学会第四届年会。
J Neuroimmune Pharmacol. 2014 Mar;9 Suppl 1:S1-3. doi: 10.1007/s11481-014-9526-4.
10
The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system.基因疗法在中枢神经系统炎性脱髓鞘疾病中的治疗应用。
Curr Opin Neurol. 2003 Jun;16(3):385-92. doi: 10.1097/01.wco.0000073941.19076.0a.

引用本文的文献

1
Nanotechnology-Powered Meningitis Therapies: Lipid Nanoparticles Lead the Way.纳米技术驱动的脑膜炎疗法:脂质纳米颗粒引领潮流。
Curr Pharm Biotechnol. 2024 May 3. doi: 10.2174/0113892010303028240429073144.
2
Biocompatible and bioactivable terpolymer-lipid-MnO Nanoparticle-based MRI contrast agent for improving tumor detection and delineation.用于改善肿瘤检测与勾勒的基于生物相容性和可生物活化的三元共聚物-脂质-MnO纳米颗粒的磁共振成像造影剂。
Mater Today Bio. 2024 Jan 17;25:100954. doi: 10.1016/j.mtbio.2024.100954. eCollection 2024 Apr.
3
Aggregation-Inhibiting scFv-Based Therapies Protect Mice against AAV1/2-Induced A53T-α-Synuclein Overexpression.基于聚集抑制 scFv 的治疗可保护小鼠免受 AAV1/2 诱导的 A53T-α-突触核蛋白过表达的影响。
Biomolecules. 2023 Jul 31;13(8):1203. doi: 10.3390/biom13081203.
4
Polymersomes Based Versatile Nanoplatforms for Controlled Drug Delivery and Imaging.基于聚合物囊泡的多功能纳米平台用于可控药物递送与成像
Adv Pharm Bull. 2023 Mar;13(2):218-232. doi: 10.34172/apb.2023.028. Epub 2022 Jan 8.
5
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders.纳米材料的最新进展:管理神经退行性疾病的一种有前途的方法。
Mol Diagn Ther. 2023 Jul;27(4):457-473. doi: 10.1007/s40291-023-00654-1. Epub 2023 May 22.
6
Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders.基于纳米医学的治疗策略在中枢神经系统疾病治疗中的作用。
Molecules. 2023 Jan 28;28(3):1283. doi: 10.3390/molecules28031283.
7
mediated biosynthesis of zinc oxide nanoparticles and evaluation of their antioxidant, cytotoxic, antimicrobial, anti-diabetic, anti-inflammatory, and anti-aging activities.氧化锌纳米颗粒的介导生物合成及其抗氧化、细胞毒性、抗菌、抗糖尿病、抗炎和抗衰老活性的评估。
Saudi J Biol Sci. 2023 Jan;30(1):103485. doi: 10.1016/j.sjbs.2022.103485. Epub 2022 Nov 1.
8
A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems.固体脂质纳米粒简述:当代药物递送系统的重要组成部分
RSC Adv. 2020 Jul 17;10(45):26777-26791. doi: 10.1039/d0ra03491f. eCollection 2020 Jul 15.
9
Advancement of nanomedicines in chronic inflammatory disorders.纳米医学在慢性炎症性疾病中的进展。
Inflammopharmacology. 2022 Apr;30(2):355-368. doi: 10.1007/s10787-022-00927-x. Epub 2022 Feb 25.
10
Stem Cell-based and Advanced Therapeutic Modalities for Parkinson's Disease: A Risk-effectiveness Patient-centered Analysis.基于干细胞的和先进的治疗模式治疗帕金森病:风险-有效性患者为中心的分析。
Curr Neuropharmacol. 2022 Nov 15;20(12):2320-2345. doi: 10.2174/1570159X20666220201100238.

本文引用的文献

1
A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease.一种新型线粒体靶向的阿朴辛衍生物可预防帕金森病富含亮氨酸重复激酶2(LRRK2(R1441G))转基因小鼠模型中的嗅觉减退和运动功能丧失。
Neurosci Lett. 2014 Nov 7;583:159-64. doi: 10.1016/j.neulet.2014.09.042. Epub 2014 Sep 26.
2
Hydrophilic carbon clusters as therapeutic, high-capacity antioxidants.亲水性碳簇作为具有治疗作用的高容量抗氧化剂。
Trends Biotechnol. 2014 Oct;32(10):501-5. doi: 10.1016/j.tibtech.2014.08.005. Epub 2014 Aug 28.
3
Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.针对艾滋病毒储存库的长效纳米制剂抗逆转录病毒疗法的研发
Curr Med Chem. 2014;21(36):4186-98. doi: 10.2174/0929867321666140826114135.
4
Potential efficacy of dopamine loaded-PVP/PAA nanogel in experimental models of Parkinsonism: possible disease modifying activity.载多巴胺的聚乙烯吡咯烷酮/聚丙烯酸纳米凝胶在帕金森病实验模型中的潜在疗效:可能的疾病修饰活性。
J Biomed Mater Res A. 2015 May;103(5):1713-20. doi: 10.1002/jbm.a.35312. Epub 2014 Aug 22.
5
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with cerebrolysin display neuroprotective activity in a rat model of concussive head injury.载有脑活素的聚(D,L-丙交酯-共-乙交酯)纳米颗粒在大鼠脑震荡损伤模型中显示出神经保护活性。
CNS Neurol Disord Drug Targets. 2014;13(8):1475-82. doi: 10.2174/1871527313666140806145540.
6
Prophylactic and therapeutic vaccination with a nanoparticle-based peptide vaccine induces efficient protective immunity during acute and chronic retroviral infection.基于纳米颗粒的肽疫苗进行预防性和治疗性接种可在急性和慢性逆转录病毒感染期间诱导有效的保护性免疫。
Nanomedicine. 2014 Nov;10(8):1787-98. doi: 10.1016/j.nano.2014.06.014. Epub 2014 Jul 9.
7
Endosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance.纳米配方抗逆转录病毒疗法的内体运输有助于药物颗粒携带和清除HIV。
J Virol. 2014 Sep 1;88(17):9504-13. doi: 10.1128/JVI.01557-14. Epub 2014 Jun 11.
8
Bench-to-bedside translation of magnetic nanoparticles.磁纳米粒子的从实验室到临床的转化。
Nanomedicine (Lond). 2014 Apr;9(4):501-16. doi: 10.2217/nnm.14.5.
9
Gadolinium-functionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imaging.基于功能化纳米氧化石墨烯的药物和 miRNA 联合递药系统及其磁共振成像研究
Biomaterials. 2014 Aug;35(24):6534-42. doi: 10.1016/j.biomaterials.2014.04.057. Epub 2014 May 6.
10
Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)-block-poly(D,L)-lactic-co-glycolic acid (PEG-PLGA) nanoparticles for the treatment of schizophrenia.载有氟哌啶醇的经鼻给予的凝集素功能化的聚(乙二醇)-嵌段-聚(D,L-丙交酯-共-乙交酯)(PEG-PLGA)纳米粒用于治疗精神分裂症。
Eur J Pharm Biopharm. 2014 May;87(1):30-9. doi: 10.1016/j.ejpb.2014.02.007. Epub 2014 Feb 18.

用于退行性、炎症性和感染性神经系统疾病的纳米神经药物。

Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

作者信息

Gendelman Howard E, Anantharam Vellareddy, Bronich Tatiana, Ghaisas Shivani, Jin Huajun, Kanthasamy Anumantha G, Liu Xinming, McMillan JoEllyn, Mosley R Lee, Narasimhan Balaji, Mallapragada Surya K

机构信息

Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.

Department of Biomedical Sciences, Iowa State University, Ames, IA USA.

出版信息

Nanomedicine. 2015 Apr;11(3):751-67. doi: 10.1016/j.nano.2014.12.014. Epub 2015 Jan 31.

DOI:10.1016/j.nano.2014.12.014
PMID:25645958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4387001/
Abstract

Interest in nanoneuromedicine has grown rapidly due to the immediate need for improved biomarkers and therapies for psychiatric, developmental, traumatic, inflammatory, infectious and degenerative nervous system disorders. These, in whole or in part, are a significant societal burden due to growth in numbers of affected people and in disease severity. Lost productivity of the patient and his or her caregiver, and the emotional and financial burden cannot be overstated. The need for improved health care, treatment and diagnostics is immediate. A means to such an end is nanotechnology. Indeed, recent developments of health-care enabling nanotechnologies and nanomedicines range from biomarker discovery including neuroimaging to therapeutic applications for degenerative, inflammatory and infectious disorders of the nervous system. This review focuses on the current and future potential of the field to positively affect clinical outcomes. From the clinical editor: Many nervous system disorders remain unresolved clinical problems. In many cases, drug agents simply cannot cross the blood-brain barrier (BBB) into the nervous system. The advent of nanomedicines can enhance the delivery of biologically active molecules for targeted therapy and imaging. This review focused on the use of nanotechnology for degenerative, inflammatory, and infectious diseases in the nervous system.

摘要

由于迫切需要为精神、发育、创伤、炎症、感染和退行性神经系统疾病开发更好的生物标志物和治疗方法,对纳米神经医学的兴趣迅速增长。由于受影响人数的增加和疾病严重程度的加剧,这些疾病全部或部分构成了重大的社会负担。患者及其护理人员生产力的丧失以及情感和经济负担再怎么强调都不为过。对改善医疗保健、治疗和诊断的需求迫在眉睫。实现这一目标的一个手段是纳米技术。事实上,近年来,有助于医疗保健的纳米技术和纳米药物的发展范围广泛,从包括神经成像在内的生物标志物发现到针对神经系统退行性、炎症性和感染性疾病的治疗应用。本综述重点关注该领域当前和未来对改善临床结果的潜力。临床编辑评论:许多神经系统疾病仍然是尚未解决的临床问题。在许多情况下,药物根本无法穿过血脑屏障进入神经系统。纳米药物的出现可以增强生物活性分子的递送,用于靶向治疗和成像。本综述重点关注纳米技术在神经系统退行性、炎症性和感染性疾病中的应用。